Bayer Healthcare LLC

Bayer Intellectual Property Gmbh

Bayer Pharmaceuticals Corporation

Bayer Pharma Aktiengesellschaft

Shihong Ying

Gan Wang

Roger Astbury Smith

Jacques P Dumas

Wendy Lee

Stephen J O'Connor

Gaetan H Ladouceur

Zhi Chen

Qingjie Liu

Furahi Achebe

Holia Mokdad

Barton W Phillips

Wai C Wong

Kyle E Parcella

Soongyu Choi

Tatiana Shelekhin

David Gunn

Mario Lobell

Ning Miao Su

Julie A Dixon

Harold C E Kluender

Christiana I Iwuagwu

Jennifer Burke

Stephan-Nicholas Wirtz

Andrea McClure

David Cantin

Derek Lowe

Xin Ma

Frederick Ehrgott

This invention relates to novel compounds of formula (I). Formula (I) in which the variable groups are as defined in the specification and claims, to pharmaceutical compositions containing them, and to a method of treatment using them for treatment of cancer. 

Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases

The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I). 

Substituted pyrazolyl urea derivatives useful in the treatment of cancer

This invention relates to substituted imidazole derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.

Preparation and use of imidazole derivatives for treatment of obesity

Growing community of inventors

Orange, CT, United States of America

Shihong Ying